These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 20179079)
1. Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo. Gersting SW; Lagler FB; Eichinger A; Kemter KF; Danecka MK; Messing DD; Staudigl M; Domdey KA; Zsifkovits C; Fingerhut R; Glossmann H; Roscher AA; Muntau AC Hum Mol Genet; 2010 May; 19(10):2039-49. PubMed ID: 20179079 [TBL] [Abstract][Full Text] [Related]
2. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059 [TBL] [Abstract][Full Text] [Related]
3. The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response. Staudigl M; Gersting SW; Danecka MK; Messing DD; Woidy M; Pinkas D; Kemter KF; Blau N; Muntau AC Hum Mol Genet; 2011 Jul; 20(13):2628-41. PubMed ID: 21527427 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations. Pey AL; Pérez B; Desviat LR; Martínez MA; Aguado C; Erlandsen H; Gámez A; Stevens RC; Thórólfsson M; Ugarte M; Martínez A Hum Mutat; 2004 Nov; 24(5):388-99. PubMed ID: 15459954 [TBL] [Abstract][Full Text] [Related]
5. The mechanism of BH4 -responsive hyperphenylalaninemia--as it occurs in the ENU1/2 genetic mouse model. Sarkissian CN; Ying M; Scherer T; Thöny B; Martinez A Hum Mutat; 2012 Oct; 33(10):1464-73. PubMed ID: 22644647 [TBL] [Abstract][Full Text] [Related]
7. A hypothesis on the biochemical mechanism of BH(4)-responsiveness in phenylalanine hydroxylase deficiency. Steinfeld R; Kohlschütter A; Ullrich K; Lukacs Z Amino Acids; 2003 Jul; 25(1):63-8. PubMed ID: 12836060 [TBL] [Abstract][Full Text] [Related]
8. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia. Thöny B; Ding Z; Martínez A FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637 [TBL] [Abstract][Full Text] [Related]
9. Wild-type phenylalanine hydroxylase activity is enhanced by tetrahydrobiopterin supplementation in vivo: an implication for therapeutic basis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Kure S; Sato K; Fujii K; Aoki Y; Suzuki Y; Kato S; Matsubara Y Mol Genet Metab; 2004; 83(1-2):150-6. PubMed ID: 15464429 [TBL] [Abstract][Full Text] [Related]
10. Structural and functional analyses of mutations of the human phenylalanine hydroxylase gene. Kim SW; Jung J; Oh HJ; Kim J; Lee KS; Lee DH; Park C; Kimm K; Koo SK; Jung SC Clin Chim Acta; 2006 Mar; 365(1-2):279-87. PubMed ID: 16253218 [TBL] [Abstract][Full Text] [Related]
11. Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype. Lindner M; Haas D; Mayatepek E; Zschocke J; Burgard P Mol Genet Metab; 2001 May; 73(1):104-6. PubMed ID: 11350190 [TBL] [Abstract][Full Text] [Related]
12. Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Gersting SW; Kemter KF; Staudigl M; Messing DD; Danecka MK; Lagler FB; Sommerhoff CP; Roscher AA; Muntau AC Am J Hum Genet; 2008 Jul; 83(1):5-17. PubMed ID: 18538294 [TBL] [Abstract][Full Text] [Related]
15. Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH. Pey AL; Desviat LR; Gámez A; Ugarte M; Pérez B Hum Mutat; 2003 Apr; 21(4):370-8. PubMed ID: 12655546 [TBL] [Abstract][Full Text] [Related]
17. Phenylalanine hydroxylase misfolding and pharmacological chaperones. Underhaug J; Aubi O; Martinez A Curr Top Med Chem; 2012; 12(22):2534-45. PubMed ID: 23339306 [TBL] [Abstract][Full Text] [Related]
18. START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients. Utz JR; Lorentz CP; Markowitz D; Rudser KD; Diethelm-Okita B; Erickson D; Whitley CB Mol Genet Metab; 2012 Feb; 105(2):193-7. PubMed ID: 22112818 [TBL] [Abstract][Full Text] [Related]
19. [Screening and diagnosis of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency with tetrahydrobiopterin loading test]. Zhang ZX; Ye J; Qiu WJ; Han LS; Gu XF Zhonghua Er Ke Za Zhi; 2005 May; 43(5):335-9. PubMed ID: 15924746 [TBL] [Abstract][Full Text] [Related]
20. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression. Waters PJ Hum Mutat; 2003 Apr; 21(4):357-69. PubMed ID: 12655545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]